Biocon engages law firm for governance review after CBI arrests
Exclusive | Biocon, Mylan Biosimilar Deal in Last Leg; Serum Institute to Buy Additional Stake of $500 Million in Biocon Biologics: Sources
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering
India's Biocon Biologics to receive $150m from Goldman Sachs - Nikkei Asia
Cash-and-stock deal: Biocon Biologics acquires Viatris for $3.33 billion | The Financial Express
Biocon logo in transparent PNG format
Biocon Biologics' antibody drug unit in Bengaluru gets EU GMP certificate | Business Standard News
Biocon Campus - Biocon
Biocon announces merger of its arm with Serum Institute subsidiary - BusinessToday
Biocon Q4 results show Consolidated revenue up by 21% - The Statesman
Biocon sells 5.4% stake in its research arm Syngene International - Hindustan Times
Biocon in pact with Japan's Yoshindo to commercialise two biosimilar assets | Mint
Covid has created an 'ecosystem' of innovation in India, says Biocon chief Kiran Mazumdar-Shaw | Mint
Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs - Biocon
Syngene International: Biocon sells 5.4% stake in arm Syngene International - The Economic Times
Biocon - Wikipedia
Biocon subsidiary acquires Viatris pharma for $3 billion | Mint
Research Centre - Biocon
Biocon Campus - Biocon
Biocon - 72 new faces joined us in February. Many... | Facebook
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
Manufacturing Operations - Biocon - Global Biopharmaceutical company
Biocon Biologics (@BioconBiologics) / Twitter
Biocon biosimilar plant criticized again by the FDA | Fierce Pharma
Biocon Biologics Limited | ISPE | International Society for Pharmaceutical Engineering
Fortune India: Business News, Strategy, Finance and Corporate Insight
